×
For best experience we recommend to activate Javascript in your browser.
CHRNE antibody (AA 409-443)
The Rabbit Polyclonal anti-CHRNE antibody has been validated for WB and FACS. It is suitable to detect CHRNE in samples from Human, Mouse and Rat.
Quick Overview for CHRNE antibody (AA 409-443) (ABIN6244209)
Target
See all CHRNE Antibodies
CHRNE
(Cholinergic Receptor, Nicotinic, epsilon (Muscle) (CHRNE))
Reactivity
All reactivities for CHRNE antibodies
Human, Mouse, Rat
Host
All hosts for CHRNE antibodies
Rabbit
Clonality
All clonalities for CHRNE antibodies
Polyclonal
Conjugate
All conjugates for CHRNE antibodies
This CHRNE antibody is un-conjugated
Application
All applications for CHRNE antibodies
Western Blotting (WB), Flow Cytometry (FACS)
Clone
RB56765
Product Details anti-CHRNE Antibody
(hide)
Binding Specificity
All epitopes for CHRNE antibodies
AA 409-443
Predicted Reactivity
M, Rat
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This CHRNE antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 409-443 amino acids from the Central region of human CHRNE.
Isotype
Ig Fraction
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:2000. FC: 1:25
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Target Details for CHRNE
(hide)
Target
CHRNE
(Cholinergic Receptor, Nicotinic, epsilon (Muscle) (CHRNE))
Alternative Name
CHRNE
Background
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Molecular Weight
54697
UniProt
Q04844
Recently viewed
(hide)
Chat with us , powered by LiveChat